NDC product
POLYETHYLENE GLYCOL 3350 NF
NDC 11534-180 · SUNRISE PHARMACEUTICAL, INC
Key facts
| Product NDC | 11534-180 |
|---|---|
| Proprietary name | POLYETHYLENE GLYCOL 3350 NF |
| Nonproprietary name | polyethylene glycol 3350 |
| Substances | POLYETHYLENE GLYCOL 3350 |
| Dosage form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Labeler | SUNRISE PHARMACEUTICAL, INC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA206105 |
| Pharmacologic classes | Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
| Marketing start | Jun 13, 2017 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: